Methotrexate in the treatment of primary biliary cirrhosis: The hype and the hope

Gastroenterology

Volumn 117, Issue 2, 1999, Pages 492-495

  Angulo, P ^a   Dickson, E R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; URSODEOXYCHOLIC ACID;

ABDOMINAL DISCOMFORT; ANTIINFLAMMATORY ACTIVITY; BONE MARROW SUPPRESSION; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; HUMAN; INTERSTITIAL PNEUMONIA; MUCOSA INFLAMMATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0032775532     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.1999.0029900492     Document Type: Article

References (41)

1. P. Angulo K.D. Lindor Management of primary biliary cirrhosis and autoimmune cholangitis Clin Liver Dis 2 1998 333 352
2. RE Poupon R Poupon B Balkau the UDCA-PBC study group Ursodiol for the treatment of primary biliary cirrhosis N Engl J Med 330 1994 1342 1347
3. K.D. Lindor T.M. Therneau R.A. Jorgensen M. Malinchoc E.R. Dickson Effects of ursodeoxycholic acid on survival of patients with primary biliary cirrhosis Gastroenterology 1110 1996 1515 1518
4. R.E. Poupon K.D. Lindor K. Cauch-Dudek E.R. Dickson R. Poupon E.J. Heathcote Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis Gastroenterology 113 1997 884 890
5. P. Angulo K.P. Batts T.M. Therneau R.A. Jorgensen E.R. Dickson K.D. Lindor Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis Hepatology 29 1999 644 647
6. M.M. Kaplan T.A. Knox Treatment of primary biliary cirrhosis with low-dose weekly methotrexate Gastroenterology 101 1991 1332 1338
7. H.S. Conjeevaram N.V. Beragasa D.E. Kleiner R. Sallie M. Wells J.H. Hoofnagle Methotrexate therapy of primary biliary cirrhosis: 2 yr study comparing two doses (abstr) Hepatology 22 1995 124A
8. N.V. Bergasa E.A. Jones D.E. Kleiner L. Rabin Y. Park M.C. Wells J.H. Hoofnagle Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis Am J Gastroenterol 91 1996 295 299
9. M.M. Kaplan R.A. Delillis H.J. Wolfe Sustained biochemical and histologic remission of primary bilair y cirrhosis in response to medical treatment Ann Intern Med 126 1997 682 688
10. M. Kaplan C. Schmid A. Mckusick D. Provenzale A. Sharma T. Sepe Double blind trial of methotrexate (MTX) versus colchicine (COLCH) in primary biliary cirrhosis (PBC) (abstr) Hepatology 18 1993 176A
11. M.M. Kaplan G. Dickstein C. Schmid Methotrexate improves histology in primary biliary cirrhosis (PBC) (abstr) Hepatology 20 1994 152A
12. N. Bach S.N. Thung F. Schaffner The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis Arch Pathol Lab Med 122 1998 342 345
13. N. Bach C. Bodian S. Thung E. Croen H. Bodenheimer Jr F. Shaffner Methotrexate therapy for primary biliary cirrhosis: five year follow-up (abstr) Hepatology 28 1998 545A
14. L. Vandeputte W. Van Steenberg Methotrexate therapy in primary biliary cirrhosis is of limited efficacy and accompanied by serious side effects (abstr) Gastroenterology 112 1997 A1406
15. A. Sharma D. Provenzale A. Mckusick M.M. Kaplan Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis Gastroenterology 107 1994 266 270
16. A. Gonzalez-Koch J. Brahm C. Antezana G. Smok M.A. Cumsille The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone J Hepatol 27 1997 147 149
17. K.D. Lindor E.R. Dickson R.A. Jorgensen M.L. Anderson R.H. Wiesner G.J. Gores S.M. Lange S.S. Rossi A.F. Hofmann W.P. Baldus The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study Hepatology 22 1995 1158 1162
18. M.T. Hendrickse E. Rigney M.H. Giaffer I. Soomro D.R. Triger J.C.E. Underwood D. Gleeson Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial Gastroenterology 117 1999 400 407
19. P.A.L. Bonis M. Kaplan Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol Gastroenterology 117 1999 395 399
20. J. Roll J.L. Boyer D. Barr y G. Klatskin The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis N Engl J Med 308 1983 1 7
21. E. Christensen J. Neuberger J. Crowe D.G. Altman H. Popper B. Portmann D. Doniach L. Ranek N. Tygstrup R. Williams Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: final results of an international trial Gastroenterology 89 1985 1084 1091
22. E.R. Dickson P.M. Grambsch T.R. Fleming L.D. Fisher A. Langworthy Prognosis in primary biliary cirrhosis: model for decision making Hepatology 10 1989 1 7
23. A. Rydning E. Schrumpf M. Abdelnoor K. Elgio E. Jenssen Factors of prognostic importance in primary biliary cirrhosis Scand J Gastroenterol 25 1990 119 126
24. B.M. Goudie A.D. Burt G.J. Macfarlane P. Boyle C.R. Gillis R.N. Macsween G. Watkinson Risk factors and prognosis in primary biliary cirrhosis [published erratum appears in Am J Gastroenterol 1989;84:1474] Am J Gastroenterol 84 1989 713 716
25. G.P. Jeffrey W.D. Reed K.B. Shilkin Natural history and prognostic variables in primary biliary cirrhosis (PBC) (abstr) Hepatology 12 1990 955
26. P.M. Grambsch E.R. Dickson M. Kaplan G. Lesage T.R. Fleming A.L. Langworthy Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability Hepatology 10 1989 846 850
27. R.G. Knodell K.G. Ishak W.C. Black T.S. Chen R. Craig N. Kaplowitz T.W. Kiernan J. Wollman Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431 435
28. J. Ludwig E.R. Dickson G.S. Mcdonald Staging of non-suppurative cholangitis (syndrome of primary biliary cirrhosis) Virchows Arch A 329 1978 103 112
29. S. Munoz R.L. Carithers Jr S.S. Emerson N. Five K. Kowdley B. Combes Absence of pulmonary toxicity in primary biliary cirrhosis (PBC) treated with methotrexate and ursodiol (abstr) Hepatology 28 1998 392A
30. M.F. Bassendine A.F. Macklon R. Mulcahy O.F.W. James Controlled trial of high and low dose d-penicillamine (DP) in primary biliary cirrhosis (PBC): results at three years (abstr) Gut 23 1982 909
31. E.R. Dickson T.R. Fleming R.H. Wiesner W.P. Baldus C.R. Fleming J. Ludwig J.T. Mccall Trial of penicillamine in advanced primary biliary cirrhosis N Engl J Med 312 1985 1011 1015
32. J.H. Hoofnagle G.L. Davis D.F. Schafer M. Peters M.I. Avigan S.C. Pappas R.G. Hanson G.Y. Minuk G.M. Dusheiko G. Campbell R.N.M. Macsween E.A. Jones Randomized trial of chlorambucil for primary biliary cirrhosis Gastroenterology 91 1986 1327 1334
33. M. Lombard B. Portmann J. Neuberger R. Williams N. Tygstrup L. Ranek H. Ring-Larsen J. Rodes M. Navasa C. Trepo G. Pape G. Schou J.H. Badsberg P.K. Andersen Cyclosporine A treatment in primary biliary cirrhosis: results of a long-term placebo-controlled trial Gastroenterology 104 1993 519 526
34. H. Bodenheimer Jr F. Schaffner J. Penzzullo Evaluation of colchicine therapy in primary biliary cirrhosis Gastroenterology 95 1988 124 129
35. A. Zifroni F. Schaffner Long-term follow up of patients with primary biliary cirrhosis on colchicine therapy Hepatology 14 1991 990 993
36. H.R. van Buuren The results of a randomized double blind trial evaluating malotilate in primary biliary cirrhosis J Hepatol 17 1993 227 235 A European multicentre study group
37. B. Combes R.L. Carithers Jr C.M. Madrey D. Lin M.F. Mcdonald D.E. Wheeler E.H. Eigenbrodt S.J. Muñoz R. Rubin G. Garcia-Tsao G.F. Bonner A.B. West J.L. Boyer V.A. Lucetic M.L. Shiffman A.S. Mills M.G. Peters H.W. White R.K. Zetterman S.S. Rossi A.F. Hofmann R.S. Markin A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis Hepatology 22 1995 759 766
38. H.P. Busher Y. Zietzschmann W. Gerok Positive response to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone J Hepatol 18 1993 9 14
39. F.H.J. Wolfhagen H.R. van Buuren S.W. Schalm Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis Neth J Med 44 1994 84 90
40. T. Ikeda S. Tozuka O. Noguchi F. Kobayashi S. Sakamoto F. Marumo C. Sato Effects of additional administration of colchicine in ursodeoxycholic acid–treated patients with primary biliary cirrhosis: a prospective randomized study J Hepatol 24 1996 88 94
41. RE Poupon PM Huet R Poupon AM Bonnand JT Van Hhieu ES Zafrani the UDCA-PBC study group A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis Hepatology 24 1996 1098 1103